Reimbursement cuts, hiring freezes and equipment purchasing holds are a reality for many radiology groups under the Affordable Care Act, according to a recent Diagnostic Imaging survey.
Reimbursement cuts, hiring freezes and equipment purchasing holds are becoming a reality for many radiology groups under the Affordable Care Act.That’s according to a recent survey of Diagnostic Imaging readers in which we sought to get an understanding of just how much the law is already impacting the industry and how much - or how little â radiology professionals understand the reforms.The results showed that although most imaging professionals have a fair understanding of the ACA, only half know where to go for more information. Groups seem split on the level of their leadership's involvement in reform discussions, too.But there’s little confusion that the law will - or is already - greatly impacting radiology. Most respondents expect pay to drop either slightly or greatly, and most are already feeling the cuts. Hiring is on hold at many facilities, as is equipment purchasing.Check out the slideshow for the full results, and tell us your experiences in the comments section below.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.